As part of the present study, we first performed WES in the patient which confirmed the previously described variant in the RYR1 gene in a heterozygous state, but did not reveal a second pathogenic or likely pathogenic variant in this gene or any other myopathy-related gene. The gene discussed is RYR1; the disease is myopathy.